Table 3.
The clinicopathological characteristics and postoperative outcomes of non-MG patients stratified by the completion of the learning curve (CLC) cut-off.
| Variable | CLC cut-off |
p | |
|---|---|---|---|
| Phase 1 (n = 16) | Phase 2 (n = 27) | ||
| Preoperative characteristics | |||
| Age (years) | 56.44 ± 15.17 | 52.19 ± 19.42 | 0.458 |
| Gender (M) | 8 (50.0%) | 9 (33.33%) | 0.280 |
| Smoking | 8 (50.0%) | 15 (55.55%) | 0.724 |
| ASA score | 1.83 ± 0.72 | 2.11 ± 0.58 | 0.254 |
| BMI | 27.02 ± 5.71 | 25.00 ± 0.00 | 0.668 |
| Thymic hyperplasia | 9 (56.25%) | 18 (66.66%) | 0.483 |
| Thymoma | 6 (37.5%) | 9 (33.33%) | |
| Thymic carcinoma | 1 (6.25%) | 0 (0%) | |
| Intraoperative results | |||
| Operative time (min) | 227.44 ± 90.54 | 169.63 ± 61.09 | 0.016 |
| Side of access (left) | 13 (81.25%) | 18 (66.66%) | 0.303 |
| Intraoperative complications | 0 (0%) | 0 (0%) | 1.00 |
| Blood loss (ml) | 25.63 ± 8.14 | 29.07 ± 16.53 | 0.441 |
| Conversion | 1 (6.25%) | 1 (3.7%) | 0.702 |
| Postoperative outcomes | |||
| Chest tube duration | 2.94 ± 1.34 | 2.67 ± 3.13 | 0.745 |
| Postoperative hospital stay | 3.63 ± 2.16 | 4.26 ± 4.69 | 0.614 |
| Thirty-day readmission | 1 (6.25%) | 2 (7.4%) | 0.885 |
| Thirty-day mortality | 0 (0%) | 0 (0%) | 1.00 |
Bold indicates p-value inferior to 0.01.